🇺🇸 FDA
Pipeline program

HCQ/CQ and CAB combined treatment

HCCT-2018

Unknown small_molecule active

Quick answer

HCQ/CQ and CAB combined treatment for Resistance, Disease is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Resistance, Disease
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials